Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-25-002560
Filing Date
2025-05-28
Accepted
2025-05-28 17:59:16
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 16861
2 EXHIBIT 99.1: JOINT FILING AGREEMENT p25-1273exhibit99_1.htm EX-99.1 9624
  Complete submission text file 0000902664-25-002560.txt   28271
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Subject) CIK: 0001643918 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-89366 | Film No.: 25996846
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1111 BRICKELL AVENUE, SUITE 2920 MIAMI FL 33131
Business Address 1111 BRICKELL AVENUE, SUITE 2920 MIAMI FL 33131 201-391-1839
C/M CAPITAL PARTNERS, LP (Filed by) CIK: 0002038499 (see all company filings)

EIN.: 991188042 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G